tiprankstipranks

Adaptive Biotechnologies price target lowered to $14 from $15 at Piper Sandler

Piper Sandler analyst David Westenberg lowered the firm’s price target on Adaptive Biotechnologies to $14 from $15 and keeps an Overweight rating on the shares. The analyst updated the company’s model post the earnings report.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on ADPT:

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue